Bulk Manufacturer of Controlled Substances Application: Groff NA Hemplex LLC, 58692 [2021-23034]
Download as PDF
<![CDATA[
58692
Federal Register / Vol. 86, No. 202 / Friday, October 22, 2021 / Notices
The company plans to import the
listed control substances for clinical
trials, research and development,
analytical purposes, and distribution to
its customers. No other activity for these
drug codes is authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Brian S. Besser,
Acting Assistant Administrator.
Controlled substance
Drug
code
Schedule
Marihuana Extract ............
Marihuana .........................
Tetrahydrocannabinols .....
7350
7360
7370
I
I
I
I
I
The company is federally authorized
to conduct cultivation activities in order
to bulk manufacture the listed
controlled substances for internal use
and for sale to federally registered
research investigators. No other
activities for these drug codes are
authorized for this registration.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–23034 Filed 10–21–21; 8:45 am]
BILLING CODE P
[FR Doc. 2021–23036 Filed 10–21–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Controlled substance
Amphetamine ..................
Methylphenidate ..............
Nabilone ..........................
Codeine ...........................
Oxycodone ......................
Hydromorphone ...............
Hydrocodone ...................
Methadone ......................
Methadone intermediate ..
Morphine ..........................
Thebaine ..........................
Oxymorphone ..................
Fentanyl ...........................
Drug
code
Schedule
1100
1724
7379
9050
9143
9150
9193
9250
9254
9300
9333
9652
9801
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to bulk
manufacture small quantities of the
listed controlled substances for internal
use or for sale as analytical reference
standard materials to its customers. No
other activities for these drug codes are
authorized for this registration.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Brian S. Besser,
Acting Assistant Administrator.
[Docket No. DEA–914]
[FR Doc. 2021–23038 Filed 10–21–21; 8:45 am]
BILLING CODE P
Bulk Manufacturer of Controlled
Substances Application: Organic
Consultants, LLC. DBA Cascade
Chemistry
[Docket No. DEA–912]
Bulk Manufacturer of Controlled
Substances Application: Groff NA
Hemplex LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice of application.
Groff NA Hemplex LLC has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 21, 2021. Such
persons may also file a written request
for a hearing on the application on or
before December 21, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on August 16, 2021, Groff
NA Hemplex LLC, 100 Redco Avenue,
Suite A, Red Lion, Pennsylvania 17356–
1436, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
lotter on DSK11XQN23PROD with NOTICES1
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:47 Oct 21, 2021
Jkt 256001
Organic Consultants, LLC.
DBA Cascade Chemistry, has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 21, 2021. Such
persons may also file a written request
for a hearing on the application on or
before December 21, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
In
accordance with 21 CFR 1301.33(a), this
is notice that on September 9, 2021,
Organic Consultants, LLC. DBA Cascade
Chemistry, 90 North Polk Street, Suite
200, Eugene, Oregon 97402–4109,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Drug Enforcement Administration
[Docket No. DEA–911]
SUMMARY:
SUMMARY:
DEPARTMENT OF JUSTICE
Importer of Controlled Substances
Application: Novitium Pharma LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Novitium Pharma LLC has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 22, 2021. Such
persons may also file a written request
for a hearing on the application on or
before November 22, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
SUMMARY:
E:\FR\FM\22OCN1.SGM
22OCN1
]]>Agencies
[Federal Register Volume 86, Number 202 (Friday, October 22, 2021)]
[Notices]
[Page 58692]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-23034]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-912]
Bulk Manufacturer of Controlled Substances Application: Groff NA
Hemplex LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Groff NA Hemplex LLC has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before December 21,
2021. Such persons may also file a written request for a hearing on the
application on or before December 21, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on August 16, 2021, Groff NA Hemplex LLC, 100 Redco
Avenue, Suite A, Red Lion, Pennsylvania 17356-1436, applied to be
registered as a bulk manufacturer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract....................... 7350 I
Marihuana............................... 7360 I
Tetrahydrocannabinols................... 7370 I
------------------------------------------------------------------------
The company is federally authorized to conduct cultivation
activities in order to bulk manufacture the listed controlled
substances for internal use and for sale to federally registered
research investigators. No other activities for these drug codes are
authorized for this registration.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-23034 Filed 10-21-21; 8:45 am]
BILLING CODE P
